AU555213B2 - N-substituted-amido-fluoresein derivatives - Google Patents

N-substituted-amido-fluoresein derivatives

Info

Publication number
AU555213B2
AU555213B2 AU80328/82A AU8032882A AU555213B2 AU 555213 B2 AU555213 B2 AU 555213B2 AU 80328/82 A AU80328/82 A AU 80328/82A AU 8032882 A AU8032882 A AU 8032882A AU 555213 B2 AU555213 B2 AU 555213B2
Authority
AU
Australia
Prior art keywords
fluoresein
amido
derivatives
substituted
fluoresein derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU80328/82A
Other languages
English (en)
Other versions
AU8032882A (en
Inventor
Michael Ernest Jolley
Stephen Denham Stroupe
Chao-Huei Jeffrey Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU8032882A publication Critical patent/AU8032882A/en
Application granted granted Critical
Publication of AU555213B2 publication Critical patent/AU555213B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU80328/82A 1981-02-17 1982-02-10 N-substituted-amido-fluoresein derivatives Ceased AU555213B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23525981A 1981-02-17 1981-02-17
US235259 1981-02-17

Publications (2)

Publication Number Publication Date
AU8032882A AU8032882A (en) 1982-08-26
AU555213B2 true AU555213B2 (en) 1986-09-18

Family

ID=22884765

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80328/82A Ceased AU555213B2 (en) 1981-02-17 1982-02-10 N-substituted-amido-fluoresein derivatives

Country Status (6)

Country Link
JP (1) JPS57150680A (it)
AU (1) AU555213B2 (it)
BE (1) BE892158A (it)
FR (1) FR2500165B1 (it)
GB (1) GB2111476B (it)
IT (1) IT1157305B (it)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1195995A (en) * 1982-11-08 1985-10-29 Curtis L. Kirkemo Substituted carboxyfluoresceins
US4476229A (en) * 1982-11-08 1984-10-09 Abbott Laboratories Substituted carboxyfluoresceins
US4476228A (en) * 1982-11-08 1984-10-09 Abbott Laboratories Determination of unsaturated thyroxine binding protein sites using fluorescence polarization techniques
US4510251A (en) * 1982-11-08 1985-04-09 Abbott Laboratories Fluorescent polarization assay for ligands using aminomethylfluorescein derivatives as tracers
US4582791A (en) * 1983-10-07 1986-04-15 Syntex (U.S.A.) Inc. Reducing non-specific background in immunofluorescence techniques
US4591569A (en) * 1984-04-11 1986-05-27 Becton Dickinson & Company Homogeneous fluorescent triiodothyronine uptake test
IL76447A0 (en) * 1984-10-25 1986-01-31 Abbott Lab Fluorescence polarization assay,reagents,and method of making reagents,for determination of digitoxin
EP0184120A3 (en) * 1984-11-29 1987-12-09 Abbott Laboratories Tracers for disopyramide assay and immunogens to raise antibody
EP0199042A1 (en) * 1985-03-26 1986-10-29 Abbott Laboratories Procainamide assay, tracers, immunogens and antibodies
DE3682105D1 (de) * 1985-04-01 1991-11-28 Abbott Lab Probe, tracers, immunogene und antikoerper von ethosuximid.
US4698315A (en) * 1985-04-22 1987-10-06 Hoffmann-La Roche Inc. Method and kit for determining total digoxin levels involving agent to dissociate digoxin-protein complex
DE3685377D1 (de) * 1985-07-22 1992-06-25 Abbott Lab Fluoreszenz-polarisation-immunotest und reagens zur messung von c-reaktivem protein.
DE3689688T2 (de) * 1985-10-15 1994-08-25 Abbott Lab Verbindungen und Immunoassay für tricyclische Antidepressiva.
US4855225A (en) * 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
US5336622A (en) * 1986-04-25 1994-08-09 Abbott Laboratories Tracers for use in flecainide fluorescence polarization immunoassay
US5155212A (en) * 1986-05-21 1992-10-13 Abbott Laboratories Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit
US5221629A (en) * 1986-05-21 1993-06-22 Abbott Laboratories Phencyclidine and phencyclidine metabolites assay, tracers, immunogens and antibodies
US5124457A (en) * 1986-05-21 1992-06-23 Abbott Laboratories Phencyclidine and phencyclidine metabolites assay, tracers, immunogens and antibodies
US4939264A (en) * 1986-07-14 1990-07-03 Abbott Laboratories Immunoassay for opiate alkaloids and their metabolites; tracers, immunogens and antibodies
US4784961A (en) * 1987-03-23 1988-11-15 Abbott Laboratories Fluorescence polarization method for monitoring fetal lung maturity
US5223627A (en) * 1986-07-15 1993-06-29 Abbott Laboratories Fluorescence polarization method for monitoring fetal lung maturity
US4868132A (en) * 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US5100807A (en) * 1987-10-19 1992-03-31 Abbott Laboratories Phenylacetylglutamine (pag) analytical test
JPH01272967A (ja) * 1988-04-26 1989-10-31 Matsushita Electric Ind Co Ltd 免疫的検出法
US5051361A (en) * 1988-10-19 1991-09-24 Sigma Chemical Company AZT immunoassays, derivatives, conjugates and antibodies
US5262333A (en) * 1988-10-28 1993-11-16 Abbott Laboratories Method and reagents for detecting amphetamine and/or D-methamphetamine in biological samples
US5073629A (en) * 1989-01-23 1991-12-17 Abbott Laboratories Methadone fluorescence polarization immunoassay
US5101015A (en) * 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
US5248791A (en) * 1989-04-10 1993-09-28 Abbott Laboratories Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
US5364796A (en) * 1989-07-11 1994-11-15 Pb Diagnostics Systems, Inc. Diagnostic assay system
US5099020A (en) * 1989-11-27 1992-03-24 Abbott Laboratories Barbiturate assay compositions and methods
US5096838A (en) * 1989-11-27 1992-03-17 Abbott Laboratories Barbiturate assay compositions and methods
EP0457213B1 (en) * 1990-05-16 1997-07-23 Abbott Laboratories Barbiturate assay, tracers, immunogens, antibodies and kit
GB9024176D0 (en) * 1990-11-07 1990-12-19 Medical Res Council Photolabile compounds,their synthesis and use as fluorophores
US5407835A (en) * 1991-07-31 1995-04-18 Abbott Laboratories Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids
US5952187A (en) * 1995-12-01 1999-09-14 Oxis International, Inc. Topiramate immunoassay
IT1298693B1 (it) * 1996-04-24 2000-01-12 Hoffmann La Roche Derivati della fluoresceina 4'-metil sostituiti

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
US4222744A (en) * 1978-09-27 1980-09-16 Becton Dickinson & Company Assay for ligands
CA1121345A (en) * 1979-03-05 1982-04-06 Robert A. Yoshida Method for competitive protein binding assays inhibiting non-specific interference

Also Published As

Publication number Publication date
AU8032882A (en) 1982-08-26
FR2500165B1 (fr) 1985-06-14
JPH0123061B2 (it) 1989-04-28
IT1157305B (it) 1987-02-11
FR2500165A1 (fr) 1982-08-20
BE892158A (fr) 1982-08-16
JPS57150680A (en) 1982-09-17
IT8219675A0 (it) 1982-02-16
GB2111476B (en) 1985-04-03
GB2111476A (en) 1983-07-06

Similar Documents

Publication Publication Date Title
AU559140B2 (en) Perhydrobicyclopyrtolyl-aminoacid derivatives
AU559727B2 (en) Cephalosphorin derivatives
AU553462B2 (en) Oxazolidinone-2 derivatives
AU555213B2 (en) N-substituted-amido-fluoresein derivatives
AU544877B2 (en) Dichloroquinoline derivatives
AU529987B2 (en) Bis-triazole derivative
AU552896B2 (en) Alkanesulfonanilide derivatives
AU560003B2 (en) Acylquinoline derivatives
AU541200B2 (en) Cyclopentapiene derivatives
AU529966B2 (en) Washer-dehydrator
AU549479B2 (en) Azolyl-phenoxy derivatives
AU554428B2 (en) Benzisoxazol-3yl derivatives
AU548087B2 (en) Substituted tetrahydropyrimidinone derivatives
AU8444982A (en) 4-amino-benzylamine derivatives
AU544455B2 (en) Apovincaminol derivatives
AU554243B2 (en) Benzylazole derivatives
AU8284582A (en) Dioxazabicyclic derivatives
AU545745B2 (en) Apovincaminol derivatives
AU546848B2 (en) Imidezole derivatives
AU1101883A (en) Mousqueton
AU526579B2 (en) N-aminoalkylimidazolidines
AU7815981A (en) Derivatives from indoloquinolizine
AU543446B2 (en) Thiazolinotriazine derivatives
AU527316B2 (en) Allophanylpiperazine derivatives
AU544088B2 (en) 3-oxy-pyridine derivatives